Search by Drug Name or NDC

NDC 69536-0133-88 Next Choice One Dose 1.5 mg/1 Details

Next Choice One Dose 1.5 mg/1

Next Choice One Dose is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Foundation Consumer Healthcare LLC. The primary component is LEVONORGESTREL.

MedlinePlus Drug Summary

Levonorgestrel is used to prevent pregnancy after unprotected sexual intercourse (sex without any method of birth control or with a birth control method that failed or was not used properly [e.g., a condom that slipped or broke or birth control pills that were not taken as scheduled]). Levonorgestrel should not be used to prevent pregnancy on a regular basis. This medication is to be used as an emergency contraceptive or backup in case regular birth control fails or is used incorrectly. Levonorgestrel is in a class of medications called progestins. It works by preventing the release of an egg from the ovary or preventing fertilization of the egg by sperm (male reproductive cells). It also may work by changing the lining of the uterus (womb) to prevent development of a pregnancy. Levonorgestrel may prevent pregnancy, but it will not prevent the spread of human immunodeficiency virus (HIV, the virus that causes acquired immunodeficiency syndrome [AIDS]) and other sexually transmitted diseases.

Related Packages: 69536-0133-88
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Levonorgestrel

Product Information

NDC	69536-0133
Product ID	69536-133_8f7e3809-e396-473e-833a-1939cf1a78be
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Next Choice One Dose
Proprietary Name Suffix	n/a
Non-Proprietary Name	levonorgestrel
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	1.5
Active Ingredient Units	mg/1
Substance Name	LEVONORGESTREL
Labeler Name	Foundation Consumer Healthcare LLC
Pharmaceutical Class	Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]
DEA Schedule	n/a
Marketing Category	NDA AUTHORIZED GENERIC
Application Number	NDA021998
Listing Certified Through	2024-12-31

Package

NDC 69536-0133-88 (69536013388)

Pricing Information	N/A
NDC Package Code	69536-133-88
Billing NDC	69536013388
Package	1 BLISTER PACK in 1 BOX, UNIT-DOSE (69536-133-88) / 1 TABLET in 1 BLISTER PACK
Marketing Start Date	2019-06-15
NDC Exclude Flag	N